Morgan Stanley Maintains Equal-Weight on CME Gr, Raises Price Target to $220
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Mike Cyprys has maintained an Equal-Weight rating on CME Group (NASDAQ:CME) and raised the price target from $215 to $220.
October 26, 2023 | 12:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on CME Group and raised the price target from $215 to $220.
The news is directly related to CME Group as Morgan Stanley has maintained an Equal-Weight rating on the company and raised the price target. This suggests that the analyst sees potential in the stock, which could lead to an increase in its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100